| 1. |
北京高血壓防治協會, 中國老年學和老年醫學學會, 北京市社區衛生協會, 等. 成人高血壓合并 2 型糖尿病和血脂異常基層防治中國專家共識 (2024 年版). 中國全科醫學, 2024, 27(28): 3453-3475, 3482.
|
| 2. |
徐莉, 葛晶, 于鵬, 等. 中國老年人慢性病及共病模式變化研究: 基于中國健康與養老追蹤調查數據. 中國全科醫學, 2024, 27(11): 1296-1302.
|
| 3. |
崔春子. 中國中老年人群疾病共病模式變化趨勢及其影響因素研究. 長沙: 中南大學, 2023.
|
| 4. |
徐小兵, 李迪, 孫揚, 等. 中國城鄉老年人慢性病共病及其影響因素的差異性研究. 中國慢性病預防與控制, 2023, 31(6): 427-432.
|
| 5. |
Tagi VM, Mainieri F, Chiarelli F. Hypertension in patients with insulin resistance: etiopathogenesis and management in children. Int J Mol Sci, 2022, 23(10): 5814.
|
| 6. |
Santoro A, Kahn BB. Adipocyte regulation of insulin sensitivity and the risk of type 2 diabetes. N Engl J Med, 2023, 388(22): 2071-2085.
|
| 7. |
Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res, 2020, 2020: 3920196.
|
| 8. |
Haffner SM. Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract, 2003, 61(Suppl 1): S9-S18.
|
| 9. |
Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism, 2021, 119: 154766.
|
| 10. |
Muzurovi? E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism, 2021, 119: 154770.
|
| 11. |
Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci, 2022, 23(2): 583.
|
| 12. |
Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci, 2019, 236: 116940.
|
| 13. |
Zhao H, Zhang J, Cheng X, et al. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res, 2023, 16(1): 9.
|
| 14. |
Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol, 2024, 23(1): 8.
|
| 15. |
Li F, Wang Y, Shi B, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol, 2024, 23(1): 16.
|
| 16. |
Gou R, Dou D, Tian M, et al. Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the United States. Front Endocrinol (Lausanne), 2024, 15: 1403858.
|
| 17. |
Han Y, Zhou Z, Zhang Y, et al. The association of surrogates of insulin resistance with hyperuricemia among middle-aged and older individuals: a population-based nationwide cohort study. Nutrients, 2023, 15(14): 3139.
|
| 18. |
Seifi N, Nosrati M, Koochackpoor G, et al. The association between hyperuricemia and insulin resistance surrogates, dietary- and lifestyle insulin resistance indices in an Iranian population: MASHAD cohort study. Nutr J, 2024, 23(1): 5.
|
| 19. |
Chen Q, Hu P, Hou X, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol, 2024, 23(1): 232.
|
| 20. |
Peng H, Pan L, Ran S, et al. Prediction of MAFLD and NAFLD using different screening indexes: a cross-sectional study in U. S. adults. Front Endocrinol (Lausanne), 2023, 14: 1083032.
|
| 21. |
朱秀媛, 顧囡囡, 陳慶, 等. 長期護理保險對老年人主觀幸福感的影響——基于 CHARLS 面板數據的實證分析. 中國衛生事業管理, 2024, 41(3): 264-268.
|
| 22. |
Zhou Z, Liu Q, Zheng M, et al. Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study. Cardiovasc Diabetol, 2024, 23(1): 213.
|
| 23. |
賈真. 老年 2 型糖尿病并阿爾茨海默病患者胰島素抵抗與 GSK-3β的關系. 廣東醫科大學學報, 2022, 40(4): 395-397.
|
| 24. |
中國高血壓防治指南修訂委員會, 高血壓聯盟(中國), 中國醫療保健國際交流促進會高血壓病學分會, 等. 中國高血壓防治指南(2024 年修訂版). 中華高血壓雜志 (中英文), 2024, 32(7): 603-700.
|
| 25. |
Gregg EW, Buckley J, Ali MK, et al. Improving health outcomes of people with diabetes: target setting for the WHO global diabetes compact. Lancet, 2023, 401(10384): 1302-1312.
|
| 26. |
Yao Y, Wang B, Geng T, et al. The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999-2018. Cardiovasc Diabetol, 2024, 23(1): 43.
|
| 27. |
羅凌風, 張增利. 中老年人群 TyG 指數及其結合肥胖指標與高血壓前期的關聯性研究. 公共衛生與預防醫學, 2022, 33(1): 58-62.
|
| 28. |
張梅, 李夢啟, 普惠婕, 等. 對比分析彝族和漢族人群 TyG-BMI 在高血壓與代謝綜合征的中介作用. 現代預防醫學, 2024, 51(13): 2325-2330.
|
| 29. |
閔行. 中老年人 TyG 指數與糖尿病的相關性隊列研究. 蘭州: 蘭州大學, 2022.
|
| 30. |
葛旭紅. TyG 指數及其聯合人體測量指標與 2 型糖尿病發病關系的研究. 遼寧大連: 大連醫科大學, 2023.
|
| 31. |
Song B, Zhao X, Yao T, et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: a population-based longitudinal cohort study. Front Endocrinol (Lausanne), 2022, 13: 907973.
|
| 32. |
Zhang S, Gao L, Li S, et al. Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study. Cardiovasc Diabetol, 2024, 23(1): 154.
|
| 33. |
Sampath Kumar A, Maiya AG, Shastry BA, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Phys Rehabil Med, 2019, 62(2): 98-103.
|
| 34. |
黃妙恩, 羅輝, 呂應年. 血管緊張素轉化酶與相關疾病的關聯機制. 廣東醫科大學學報, 2023, 41(3): 335-339.
|
| 35. |
蘇峰祥, 楊景, 唐春梅, 等. 奧美沙坦酯片聯合苯磺酸氨氯地平片或絡活喜治療原發性高血壓的比較觀察. 廣東醫科大學學報, 2023, 41(4): 440-443.
|
| 36. |
Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich), 2021, 23(3): 529-537.
|
| 37. |
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab, 2010, 95(7): 3347-3351.
|
| 38. |
Yang S, Shi X, Liu W, et al. Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study. Front Endocrinol (Lausanne), 2023, 14: 1294909.
|
| 39. |
Huang X, He J, Wu G, et al. TyG-BMI and hypertension in Normoglycemia subjects in Japan: a cross-sectional study. Diab Vasc Dis Res, 2023, 20(3): 14791641231173617.
|